Transfusion for Patients with Bone Marrow Failure: When to Use Irradiated Blood Products

Transfusion for Patients with Bone Marrow Failure: When to Use Irradiated Blood Products

Disorders^*	Chemotherapy/immunosuppression agents^*
Hodgkin lymphoma Patients <6 months post allogeneic bone marrow transplant Patients with chronic graft-versus-host disease post allogeneic transplant Patients <3 months post autologous transplant (high dose therapy and stem cell rescue) T lymphocyte immunodeficiency syndromes	Fludarabine Cladribine Deoxycoformicin Clofarabine Bendamustine Alemtuzumab (Campath) Anti-thymocyte globulin

Disorders^*

Chemotherapy/immunosuppression agents^*

Hodgkin lymphoma

Patients <6 months post allogeneic bone marrow transplant

Patients with chronic graft-versus-host disease post allogeneic transplant

Patients <3 months post autologous transplant (high dose therapy and stem cell rescue)

T lymphocyte immunodeficiency syndromes

Blood bank and the duty clinical haematologist on call should be contacted for advice.